Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola [Yahoo! Finance]
Cibus, Inc. - Class A (CBUS)
Company Research
Source: Yahoo! Finance
Builds upon Cibus' progress with its Sclerotinia resistance trait in Canola after Field Trial results for its 2 nd mode of action showed enhanced disease resistance SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has successfully completed edits in Canola for its 4th mode of action for its Sclerotinia resistance trait and expects greenhouse results in the first quarter of 2025. Multiple modes of action, which are akin to a plant's defenses to disease, are critical for durable disease resistance. This advancement builds upon the Company's previously announced field trial results for its 2 nd mode of action showing enhanced resistance to Sclerotinia in Canola plants edited with Cibus' Sclerotinia resistance trait. Greg Gocal, PhD, Co-Founder, Executive Vice President and Chief Scientific Officer at Cibus,
Show less
Read more
Impact Snapshot
Event Time:
CBUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CBUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CBUS alerts
High impacting Cibus, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
CBUS
News
- Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in CanolaGlobeNewswire
- Cibus, Inc. (NASDAQ: CBUS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.MarketBeat
- Cibus Inc (CBUS) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing ... [Yahoo! Finance]Yahoo! Finance
- Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024GlobeNewswire
- Cibus Inc (CBUS) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]Yahoo! Finance
CBUS
Earnings
- 11/7/24 - Miss
CBUS
Sec Filings
- 11/13/24 - Form 4
- 11/13/24 - Form 3/A
- 11/7/24 - Form 10-Q
- CBUS's page on the SEC website